Wonderbelly plans to raise Series A as early as Q4

Wonderbelly, which markets itself as a healthy-for-you antacid alternative to Tums, is planning a Series A as it plots more retail rollouts, CEO Noah Kraft tells Axios.

Why it matters: Over-the-counter products have drawn interest from consumer product goods companies, early-stage investors, biotech firms and large retailers.